Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Mar 22, 2021 9:50 AM - Mar 24, 2021 2:30 PM

(Eastern Standard Time)

Medical Affairs and Scientific Communications Forum

Session 5 Track 2: Labeling Across Borders, Audiences, and Technologies

Session Chair(s)

Dan  Benau, PHD

Dan Benau, PHD

Director, Biomedical Writing Programs, University of the Sciences, United States

This session will provide an overview of labeling for prescription medicines and efforts to expand its audience to patients as well as prescribers. It will highlight the global influences and mechanisms in pharmaceutical product labeling, and consider the possible uses of technology.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify the changing audiences for labeling of prescription medicines
  • Discuss the global influences on essential product information
  • Evaluate the promise of certain technology for healthcare product labeling

Speaker(s)

Cathleen  O'Connell, PHD, MS, RPH

Cathleen O'Connell, PHD, MS, RPH

Assistant Professor, University of the Sciences, Misher College, United States

Adding the Patient to the Audience for Written Information About Prescription Medicines

Cathleen  O'Connell, PHD, MS, RPH

Cathleen O'Connell, PHD, MS, RPH

Assistant Professor, University of the Sciences, Misher College, United States

Global Considerations in Pharmaceutical Product Labeling

Ameesha D Batheja, PHD, MSC

Ameesha D Batheja, PHD, MSC

Director, Regional Regulatory Affairs, Janssen Pharmaceuticals, United States

Global Considerations in Pharmaceutical Product Labeling

Jaquetta  Lee, MS

Jaquetta Lee, MS

Associate Content Steward, Merck & Co., Inc., United States

The Promise of Artificial Intelligence in the Drug Labeling Process

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.